or Try an Advanced Search...

    Seth Lederman Stocks List

    Symbol Grade Name % Change
    VCNX D Vaccinex, Inc. 1.62
    TNXP D Tonix Pharmaceuticals Holding Corp. 2.47
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Antibodies Antibody Autoimmune Disorders Biology Biotechnology Cancer Clinical Development Degenerative Disease Disorders Drugs Fibromyalgia Headache Health Sciences Human Monoclonal Antibodies Immune Disorders Immune System Immunology Melanoma Monoclonal Antibodies Multiple Sclerosis

    Seth Lederman Stocks Recent News

    Date Stock Title
    Nov 18 TNXP Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
    Nov 18 TNXP Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
    Related Industries: Biotechnology
    Related Stock Lists: Antibodies Antibody Autoimmune Disorders Biology Biotechnology Cancer Clinical Development Degenerative Disease Disorders Drugs Fibromyalgia Headache Health Sciences Human Monoclonal Antibodies Immune Disorders Immune System Immunology Melanoma Monoclonal Antibodies Multiple Sclerosis
    Seth Lederman

    Seth Lederman (born July 30, 1957) is a physician, scientist and specialty pharmaceuticals entrepreneur. He is a co-founder and the current President and Chairman of Tonix Pharmaceuticals, a specialty pharmaceutical product development and commercialization company.

    More about Seth Lederman
    Browse All Tags